# USE OF 18FDG PET-CT TO PREDICT THE RESPONSE OF MANDIBULAR OSTEORADIONECROSIS TO THE PENTOCLO PROTOCOL WITH DOCUMENTED ANTIBIOTHERAPY

> **NCT04826445** · — · UNKNOWN · sponsor: **Gustave Roussy, Cancer Campus, Grand Paris** · enrollment: 75 (estimated)

## Conditions studied

- Mandibular Osteoradionecrosis

## Interventions

- **OTHER:** Data collection

## Key facts

- **NCT ID:** NCT04826445
- **Lead sponsor:** Gustave Roussy, Cancer Campus, Grand Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-06-11
- **Primary completion:** 2022-06
- **Final completion:** 2024-06
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2021-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04826445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04826445, "USE OF 18FDG PET-CT TO PREDICT THE RESPONSE OF MANDIBULAR OSTEORADIONECROSIS TO THE PENTOCLO PROTOCOL WITH DOCUMENTED ANTIBIOTHERAPY". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04826445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*